MSN571/MSN 571 PHARM MIDTERM (4 LATEST MIDTERM VERSIONS) ALL QUESTIONS AND CORRECT ANSWERS |A+ GUARANTEED!! BRAND NEW 2024 VERSION A

MSN571/MSN 571 PHARM MIDTERM (4 LATEST MIDTERM VERSIONS) ALL QUESTIONS AND CORRECT ANSWERS |A+ GUARANTEED!! BRAND NEW 2024 VERSION A 1. Fluoroquinolone antibiotics are mostlikely indicating in which of the conditions Asthma Genital infections Follicular conjunctivitis GERD 2. Which of the following is most likely an intervention for otitis media? Amoxicillin Aspirin Immunoglobulins Corticosteroids 3. Which of the following best classifies penicillin, cephalosporins, and Protein synthesis inhibitors Mycolic acid synthesis inhibitors RNA synthesis Cellwall inhibitors 4. Beta lactamase inhibitors are often located in which of the following? May decrease absorption First dose effect Often combined with penicillin antibiotics Delayed absorption of oral drugs 5. Which of the following drug classes is/are used in initial hypertension management of African American population? Clonidine primary Beta blockers primary Thiazide or calcium channel blocker primary ACE-I primary ARB primary 6. Which of the following groups of antibiotics is notable for side effects such as nephrotoxicity or ototoxicity? Beta-lactams Aminoglycosides Tetracyclines 7. Which of the following groups of antibiotics has a beta-lactam ring in the molecular Structure Sulfonamides Macrolides Tetracyclines Fluoroquinolone Cephalosporins 8. Which of the follow medication is a fluoroquinolone antibiotic? Ciprofloxacin Azithromycin Amikacin Penicillin 9. Which of the following medications or drugs classes is commonly indicated for managing gestational hypertension? Spironolactone (Aldactone) Loop diuretics Calcium channel blockers Dobutamine Calcium gluconate 10.Which ofthe following best classifies aminoglycosides, macrolides and clindamycin? Protein synthesis inhibitor Folic acid synthesis inhibitors Cell wall inhibitors Mycolic acid synthesis inhibitors 11. The long half-life of amiodarone contributes to which complications Enhanced therapeutic effects Liver toxicity Decreased dosing Short onset of action